How the product works:
Inhibits RNA-dependent RNA polymerase, stopping virus replication
Decreases viral load
Helps relieve symptoms like fever, cough, fatigue
Reduces duration of illness
Recommended for:
Adults diagnosed with mild to moderate COVID-19
Patients suffering from RNA-virus-related influenza
Individuals prescribed antiviral therapy by a physician
Treatment of mild to moderate COVID-19
Treatment of RNA-virus-related influenza
Taken orally according to the physician’s dosage schedule. Typically starts with a higher loading dose, followed by maintenance doses over several days. Can be taken with or without food, with water.
Contraindications:
Hypersensitivity to Favipiravir
Pregnancy and breastfeeding
Severe renal or hepatic impairment
Children under 18 years old
Side effects:
Elevated uric acid levels
Liver function disturbances
Nausea, diarrhoea
Headache
Allergic skin reactions (rash, itching)
